Work

BRIGHTSTAR: A pilot trial of local consolidative therapy (LCT) with brigatinib in tyrosine kinase inhibitor (TKI)-naïve ALK-rearranged advanced NSCLC.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.9624

Authors: Yasir Elamin, Saumil Gandhi, Mara Antonoff, Frank Mott, Don Lynn Gibbons, Xiuning Le, Marcelo Vailati Negrao, Boris Sepesi, Jose A. Karam, Tina Cascone, Linghua Wang, George Blumenschein, Bonnie S. Glisson, Anne S. Tsao, John Heymach

Institutions: The University of Texas MD Anderson Cancer Center, Instituto do Câncer do Estado de São Paulo

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3029018478

Cites:

Cited by: 14

Related to: 10